Asia Pacific to Register Fastest Growth at 14.1% CAGR Through Forecast Period The Asia Pacific GLP-1 receptor agonist market is projected to witness the fastest growth rate of CAGR 14.1% during the forecast period, driven by a rapidly rising prevalence of diabetes and obesity across major economies such as China, India, and Japan
Meanwhile, ongoing clinical research and rising demand for broad, comprehensive treatment options keep pushing adoption across different regions, year after year
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context around individual metabolic predispositions in GLP-1 receptor pathways and related genes like FTO and MC4R
GLP-1 Receptor Agonist Market Revenue Share By Application 9.2
Studies report that selenium supplements increased serum glutathione levels in just three months
The most common skincare ingredient of all